SNCA and Parkinson disease: In addition, we provided preclinical evidence that IR impairs mitochondrial function by suppressing PGC-1α expression, which elicits enhanced oxidative stress, increased PLK2 activity, and upregulated expression of phosphorylated and proteinase K-resistant SNCA, which is pathognomonic of PD.